Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department
Recruiting
N/A
Interventional Study
Snoezelen
Pediatric Cancer
Symptomatologie Anxieuse
Chimiothérapie
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 8 – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 20 (estimated)
- Sponsor
- Centre Oscar Lambret · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate whether the Snoezelen multisensory relaxation approach can reduce anxiety symptoms in children and adolescents aged 8 to 17 years hospitalized for chemotherapy in a pediatric oncology unit.
Researchers will compare patients' symptoms during a chemotherapy cycle with Snoezelen sessions to a previous cycle without Snoezelen, in order to assess changes …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* New patient
* Treated in the Paediatrics/AJA department of the Oscar Lambret Centre for cancer (all types of cancer)
* Hospitalisation for several days
* Highly emetogenic chemotherapy treatment: this corresponds to all in-patient treatments carried out in the Paediatrics/AJA …
Contacts